Manganese-iron Layered Double Hydroxide: a Theranostic Nanoplatform with PH-responsive MRI Contrast Enhancement and Drug Release
Overview
Authors
Affiliations
Stimuli-responsive theranostic platforms are highly desirable for efficient cancer treatment because of their improved specificity and sensitivity. In this work, we report a manganese-iron layered double hydroxide (MnFe-LDH) for the first time and demonstrate that it can serve as a pH-responsive nanoplatform for cancer theranostics. The MnFe-LDH can respond to the acidic microenvironment of solid tumors to release paramagnetic Mn and Fe ions, resulting in great enhancement of the T MRI contrast of the tumor area. In addition, the layered structure enables MnFe-LDH to effectively deliver chemotherapeutic drugs in a pH-controlled manner, and therefore it can simultaneously inhibit the growth of solid tumors. We believe that this novel MnFe-LDH with pH-responsive property holds great promise in cancer theranostic applications.
Kumar Deb V, Jain U Drug Deliv Transl Res. 2024; 14(11):3009-3031.
PMID: 38713400 DOI: 10.1007/s13346-024-01572-3.
Li Q, Wu X, Mu S, He C, Ren X, Luo X Adv Sci (Weinh). 2023; 10(20):e2207759.
PMID: 37129318 PMC: 10369261. DOI: 10.1002/advs.202207759.
Biofunctional Layered Double Hydroxide Nanohybrids for Cancer Therapy.
Lee J, Seo H, Park W, Park C, Jeon Y, Park D Materials (Basel). 2022; 15(22).
PMID: 36431465 PMC: 9694224. DOI: 10.3390/ma15227977.
Zhang H, Zhang J, Chen Y, Wu T, Lu M, Chen Z Nanoscale Adv. 2022; 4(5):1414-1421.
PMID: 36133683 PMC: 9417868. DOI: 10.1039/d1na00771h.
Zhang H, Zhang J, Zhang Q, Liu X, Yang Y, Ling Y Nanoscale Adv. 2022; 2(11):5296-5304.
PMID: 36132027 PMC: 9417305. DOI: 10.1039/d0na00714e.